- Motley Fool•18 days ago
Idera's recent shuffling of its pipeline priorities calls into question just how much potential its drug candidates actually have.
- 24/7 Wall St.•19 days ago
The late-summer doldrums are over and the markets are on the move again as we are now in the fourth quarter. But a few companies held the market back from pushing even higher.
Idera Pharmaceuticals, Inc. (IDRA)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||1.70 x 300|
|Ask||1.87 x 2400|
|Day's Range||1.70 - 1.85|
|52wk Range||1.19 - 4.42|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.13|
|Avg Vol (3m)||1,299,512|
|Dividend & Yield||N/A (N/A)|